InvestorsHub Logo

biopearl

11/18/16 9:12 AM

#16170 RE: DewDiligence #16169

Dew, also don't you think Momenta's autoimmune programs are less (or not at all) encumbered by the looming IP/patent battles that have littered the landscape? bp